BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01350401-completion@plaintrial.com
DTSTAMP:20261027T171305Z
DTSTART;VALUE=DATE:20180301
SUMMARY:Phase I/II Study to Assess the Safety and Activity of Enhanced TCR 
 Transduced Autologous T Cells in Metastatic Melanoma — estimated complet
 ion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT01350401
URL:https://plaintrial.com/trial/NCT01350401
END:VEVENT
END:VCALENDAR